Clinical Safety

Dual-Responsive Nanodelivery – Review
Research & Development Dual-Responsive Nanodelivery – Review

Sophisticated nanodelivery systems that respond to multiple biological cues are rapidly redefining the landscape of targeted therapeutics, offering a highly precise method for overcoming the formidable barriers presented by diseases like metastatic cancer. This review explores the evolution of

Why Is Bladder Cancer More Deadly for the Colorblind?
Research & Development Why Is Bladder Cancer More Deadly for the Colorblind?

A faint tinge of pink swirling in the toilet bowl is an unmistakable alarm bell for most, signaling an urgent need for medical attention, but for millions, this critical warning sign of a potentially treatable cancer remains completely invisible. New research reveals a shocking reality: individuals

FDA Warns of Dangerous Online Cancer Scams
Research & Development FDA Warns of Dangerous Online Cancer Scams

In the face of a life-altering diagnosis, the search for hope can lead patients and their families down countless digital rabbit holes, where unscrupulous vendors lie in wait with promises of miraculous cures sold through slick websites and persuasive social media campaigns. The U.S. Food and Drug

Targeted mRNA Therapy Restores Fertility in Mice
Research & Development Targeted mRNA Therapy Restores Fertility in Mice

In a landmark development for reproductive medicine, a novel messenger RNA (mRNA) treatment has successfully repaired uterine damage and restored fertility in mice, offering a potential new path forward for treating certain forms of human infertility. The study, detailed in Nature Nanotechnology ,

What Is the Immune System’s Achilles’ Heel?
Research & Development What Is the Immune System’s Achilles’ Heel?

A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue

Large Study Finds No Stomach Cancer Risk From PPIs
Research & Development Large Study Finds No Stomach Cancer Risk From PPIs

For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later